GoodRx Holdings, Inc. Deferred Federal Income Tax Expense (Benefit)
GoodRx Holdings, Inc. (GDRX) reported Deferred Federal Income Tax Expense (Benefit) of $19.44 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-26
- GoodRx Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $19.44M.
- GoodRx Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$9.41M.
- GoodRx Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$41.86M.
- GoodRx Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$421.00K, a 106.46% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $19.44M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$9.41M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$41.86M 10-K · filed 2026-02-26 |
| 2022-12-31 | -$421.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $6.52M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$7.47M 10-K · filed 2023-03-01 |
| 2019-12-31 | -$4.67M 10-K · filed 2022-03-01 |
| 2018-12-31 | -$1.79M 10-K · filed 2021-03-12 |